Literature DB >> 35975247

CIRCULATING MIR-132, MIR-146A, MIR-222, AND MIR-320 EXPRESSION IN DIFFERENTIAL DIAGNOSIS OF WOMEN WITH POLYCYSTIC OVARY SYNDROME.

Z Soyman1, S Durmus2, S Ates3, G Simsek4, V Sozer5, B P Kundaktepe6, D Kurtulus7, R Gelisgen2, V Sal8, H Uzun9.   

Abstract

Purpose: The aim of the study was to investigate whether the circulating miR-132, miR-146a, miR-222, and miR-320 levels are used in the differential diagnosis of women with polycystic ovary syndrome (PCOS) and healthy women.
Methods: This prospective case-control study included 50 women with PCOS and age- and body mass index- matched 50 healthy controls. The hormone and lipid profiles, levels of microRNAs (miRNAs), and parameters of carbohydrate metabolism were measured.
Results: Expression levels of miRNAs were assessed using the two-step quantitative real-time polymerase chain reaction. Circulating miR-132, miR-146a and miR-222 levels were significantly downregulated in the PCOS group compared with the control group. The miR-320 levels did not differ between the two groups. Free testosterone was negatively correlated with miR-132, miR-146a and miR-222. Insulin was negatively correlated with miR-132 and miR-146a. Conclusions: The results of the study revealed that miRNA expression, may suggest a possible distinction between healthy women and PCOS patients. miR-132, miR-146a, and miR-222 may have key functions in the pathogenesis of PCOS. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Polycystic ovary syndrome; miR-132; miR-146a; miR-222

Year:  2022        PMID: 35975247      PMCID: PMC9365421          DOI: 10.4183/aeb.2022.13

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  30 in total

1.  New hope for a microRNA therapy for liver cancer.

Authors:  John J Rossi
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

2.  Compact and broadband mode multiplexer and demultiplexer based on asymmetric plasmonic-dielectric coupling.

Authors:  Mei Yin; Qingzhong Deng; Yanping Li; Xingjun Wang; Hongbin Li
Journal:  Appl Opt       Date:  2014-09-20       Impact factor: 1.980

3.  A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

Authors:  M Asunción; R M Calvo; J L San Millán; J Sancho; S Avila; H F Escobar-Morreale
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

4.  Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.

Authors:  M Balasubramanyam; S Aravind; K Gokulakrishnan; P Prabu; C Sathishkumar; H Ranjani; V Mohan
Journal:  Mol Cell Biochem       Date:  2011-01-20       Impact factor: 3.396

5.  Influence of Insulin on LH, Testosterone and SHBG in various PCOS Categories based on the Mode of Secretion of LH in relation to FSH Levels.

Authors:  N A Malini; G K Roy
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

6.  Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.

Authors:  Yongyong Shi; Han Zhao; Yuhua Shi; Yunxia Cao; Dongzi Yang; Zhiqiang Li; Bo Zhang; Xiaoyan Liang; Tao Li; Jianhua Chen; Jiawei Shen; Junzhao Zhao; Li You; Xuan Gao; Dongyi Zhu; Xiaoming Zhao; Ying Yan; Yingying Qin; Wenjin Li; Junhao Yan; Qingzhong Wang; Junli Zhao; Ling Geng; Jinlong Ma; Yueran Zhao; Guang He; Aiping Zhang; Shuhua Zou; Aijun Yang; Jiayin Liu; Weidong Li; Baojie Li; Chunling Wan; Ying Qin; Juanzi Shi; Jing Yang; Hong Jiang; Jin-e Xu; Xiujuan Qi; Yun Sun; Yajie Zhang; Cuifang Hao; Xiuqing Ju; Dongni Zhao; Chun-e Ren; Xiuqing Li; Wei Zhang; Yiwen Zhang; Jiangtao Zhang; Di Wu; Changming Zhang; Lin He; Zi-Jiang Chen
Journal:  Nat Genet       Date:  2012-08-12       Impact factor: 38.330

7.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.

Authors:  Xi Chen; Yi Ba; Lijia Ma; Xing Cai; Yuan Yin; Kehui Wang; Jigang Guo; Yujing Zhang; Jiangning Chen; Xing Guo; Qibin Li; Xiaoying Li; Wenjing Wang; Yan Zhang; Jin Wang; Xueyuan Jiang; Yang Xiang; Chen Xu; Pingping Zheng; Juanbin Zhang; Ruiqiang Li; Hongjie Zhang; Xiaobin Shang; Ting Gong; Guang Ning; Jun Wang; Ke Zen; Junfeng Zhang; Chen-Yu Zhang
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

8.  Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.

Authors:  Francisco J Ortega; Josep M Mercader; José María Moreno-Navarrete; Oscar Rovira; Ester Guerra; Eduardo Esteve; Gemma Xifra; Cristina Martínez; Wifredo Ricart; Jennifer Rieusset; Sophie Rome; Monika Karczewska-Kupczewska; Marek Straczkowski; José Manuel Fernández-Real
Journal:  Diabetes Care       Date:  2014-01-29       Impact factor: 19.112

9.  Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo.

Authors:  Qing Sang; Zhongyuan Yao; Huan Wang; Ruizhi Feng; Haojue Wang; Xinzhi Zhao; Qinghe Xing; Li Jin; Lin He; Lingqian Wu; Lei Wang
Journal:  J Clin Endocrinol Metab       Date:  2013-05-10       Impact factor: 5.958

10.  Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus.

Authors:  Chun Zhao; Jing Dong; Tao Jiang; Zhonghua Shi; Bin Yu; Yunlong Zhu; Daozhen Chen; Junrong Xu; Ran Huo; Juncheng Dai; Yankai Xia; Shiyang Pan; Zhibin Hu; Jiahao Sha
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.